LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 4,506 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 3,279 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 64.42 | 3,700 | 238,354 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 146.59 | 104 | 15,245 | 34,013 | 34.1 K to 34 K (-0.30 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 1,038 | 0 | 34,117 | 33.1 K to 34.1 K (+3.14 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Sell | S | 146.06 | 3,700 | 540,407 | 33,079 | 36.8 K to 33.1 K (-10.06 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 64.42 | 3,700 | 238,354 | 36,779 | 33.1 K to 36.8 K (+11.19 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 146.59 | 52,300 | 7,666,657 | 52,300 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 12,710 | 0 | 23,957 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 3,513 | 0 | 11,247 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 146.59 | 1,571 | 230,293 | 246,281 | 247.9 K to 246.3 K (-0.63 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 3,513 | 0 | 247,852 | 244.3 K to 247.9 K (+1.44 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Buy | M | 0.00 | 1,038 | 0 | 8,769 | 7.7 K to 8.8 K (+13.43 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 0.00 | 1,038 | 0 | 19,133 | 18.1 K to 19.1 K (+5.74 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Buy | M | 0.00 | 1,038 | 0 | 7,225 | 6.2 K to 7.2 K (+16.78 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Buy | M | 0.00 | 1,038 | 0 | 3,861 | 2.8 K to 3.9 K (+36.77 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 306 | 0 | 306 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,038 | 0 | 15,209 | 14.2 K to 15.2 K (+7.32 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Buy | M | 0.00 | 1,038 | 0 | 6,462 | 5.4 K to 6.5 K (+19.14 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Gift | G | 0.00 | 610 | 0 | 5,424 | 6 K to 5.4 K (-10.11 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 147.00 | 1,038 | 152,586 | 7,886 | 8.9 K to 7.9 K (-11.63 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,038 | 0 | 8,924 | 7.9 K to 8.9 K (+13.16 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 233 | 0 | 764 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 146.59 | 64 | 9,382 | 28,823 | 28.9 K to 28.8 K (-0.22 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 233 | 0 | 28,887 | 28.7 K to 28.9 K (+0.81 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 146.59 | 3,800 | 557,042 | 3,800 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 0.00 | 930 | 0 | 1,771 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 256 | 0 | 841 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 146.59 | 103 | 15,099 | 4,489 | 4.6 K to 4.5 K (-2.24 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 256 | 0 | 4,592 | 4.3 K to 4.6 K (+5.90 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,047 | 0 | 3,334 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,830 | 0 | 6,381 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 144.29 | 905 | 130,582 | 19,687 | 20.6 K to 19.7 K (-4.39 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 3,047 | 0 | 20,592 | 17.5 K to 20.6 K (+17.37 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 144.29 | 544 | 78,494 | 17,545 | 18.1 K to 17.5 K (-3.01 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,830 | 0 | 18,089 | 16.3 K to 18.1 K (+11.26 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,047 | 0 | 997 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 4,044 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.29 | 905 | 130,582 | 8,593 | 9.5 K to 8.6 K (-9.53 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,047 | 0 | 9,498 | 6.5 K to 9.5 K (+47.23 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.29 | 132 | 19,046 | 6,451 | 6.6 K to 6.5 K (-2.01 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 6,583 | 6.1 K to 6.6 K (+7.34 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 604 | 0 | 1,097 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 144.29 | 240 | 34,630 | 4,336 | 4.6 K to 4.3 K (-5.24 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 604 | 0 | 4,576 | 4 K to 4.6 K (+15.21 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 450 | 0 | 837 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 144.29 | 124 | 17,892 | 9,770 | 9.9 K to 9.8 K (-1.25 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 450 | 0 | 9,894 | 9.4 K to 9.9 K (+4.76 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,544 | 0 | 14,760 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 144.29 | 2,980 | 429,984 | 244,339 | 247.3 K to 244.3 K (-1.20 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,544 | 0 | 247,319 | 239.8 K to 247.3 K (+3.15 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 520 | 0 | 997 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 144.29 | 143 | 20,633 | 28,654 | 28.8 K to 28.7 K (-0.50 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 520 | 0 | 28,797 | 28.3 K to 28.8 K (+1.84 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 6,100 | 0 | 18,374 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 144.29 | 1,973 | 284,684 | 14,792 | 16.8 K to 14.8 K (-11.77 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 6,100 | 0 | 16,765 | 10.7 K to 16.8 K (+57.20 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,863 | 0 | 24,474 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 147.46 | 556 | 81,988 | 10,665 | 11.2 K to 10.7 K (-4.95 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 1,863 | 0 | 11,261 | 9.4 K to 11.3 K (+19.82 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 4,220 | 0 | 22,304 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 147.46 | 1,254 | 184,915 | 239,775 | 241 K to 239.8 K (-0.52 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 4,220 | 0 | 241,029 | 236.8 K to 241 K (+1.78 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 993 | 0 | 8,211 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 147.46 | 297 | 43,796 | 16,259 | 16.6 K to 16.3 K (-1.79 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 993 | 0 | 16,556 | 15.6 K to 16.6 K (+6.38 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 297 | 0 | 1,517 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 147.46 | 82 | 12,092 | 28,277 | 28.4 K to 28.3 K (-0.29 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 297 | 0 | 28,359 | 28.1 K to 28.4 K (+1.06 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 247 | 0 | 1,287 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 147.46 | 68 | 10,027 | 9,444 | 9.5 K to 9.4 K (-0.71 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 247 | 0 | 9,512 | 9.3 K to 9.5 K (+2.67 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 327 | 0 | 1,701 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 147.46 | 148 | 21,824 | 3,972 | 4.1 K to 4 K (-3.59 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 327 | 0 | 4,120 | 3.8 K to 4.1 K (+8.62 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 297 | 0 | 4,494 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 147.46 | 104 | 15,336 | 6,133 | 6.2 K to 6.1 K (-1.67 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 297 | 0 | 6,237 | 5.9 K to 6.2 K (+5.00 %) |